- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03621787
Assessing the Safety and Efficacy of a Novel Subcutaneous Implant Insertion Device on Healthy Adults
Assessing the Safety and Efficacy of the SubQ Assist Implant Insertion Device
The investigators have created a device designed to make it easier to insert pharmaceutical implants under the skin. The device uses a blood pressure cuff to hold the skin on a person's arm in place while a mechanical guide places implants underneath the skin. This device may prevent implants from being embedded too deeply.
The investigators are performing this study to determine the safety and efficacy of the device for use in adult women. The study will determine if the implants are placed accurately under the skin (in the sub-dermal layer). It will also assess if the device causes any discomfort or last pain from use.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Subcutaneous contraceptive implants are one of the preferred methods of long-term contraception by the World health Organization and ministries of health in low- and middle-income countries. These implants offer between three and five years of protection (allowing women to safely space pregnancies and thereby reduce maternal and infant mortality), are 99.95% efficacious, allow women to return to fertility quickly when removed, requires no daily/monthly effort on the part of the woman, and cause minimal side effects in comparison to other methods. However, availability of contraceptive implants in rural areas is limited due to the skill necessary to administer them safely and accurately.
The investigators have created a device designed to make it easier to insert pharmaceutical implants under the skin. The device uses a blood pressure cuff to hold the skin on a person's arm in place while a mechanical guide places implants underneath the skin. This device is designed to prevent implants from being embedded too deeply.
In this trial, the investigators will use the implant insertion device with a placebo sub-cutaneous implant. Implants will be inserted with the device and the accuracy of the placement will be assessed through palpation and ultrasound depth measurements. This data will allow the investigators to assess whether the device ensures accurate insertions of sub-cutaneous implants.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Michigan
-
Ann Arbor, Michigan, Estados Unidos, 48109
- University of Michigan
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Healthy adult subjects aged 18 to 49
- Ability to understand study procedure and informed consent document
Exclusion Criteria:
- Patients with a history of keloid scarring
- Pregnancy
- Any rashes or skin conditions around the insertion site
- Known silicone allergies
- Known allergy to lidocaine
- History of bleeding disorders or abnormal bleeding
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Single arm study: implant insertion
Participants in trial will be within a single study arm.
All participants will have a placebo subcutaneous implant inserted with the device being studied.
The implant accuracy will be assess through palpation and ultrasound depth measurements.
The implant will then be removed.
Safety will be assessed by measuring bruising and bleeding.
A follow-up questionnaire will assess bruising and infection risk.
A final visit will assess bruising and infection risk by a physician.
|
Device designed to assist healthcare providers in administering subcutaneous implants safely and accurately.
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Implant Depth: Distal End
Periodo de tiempo: Up to 60 minutes after insertion
|
Depth of distal end of implant beneath the skin after insertion.
Measured via high frequency ultrasound with linear probe.
Measured in centimeters below skin surface.
Measurements will be aggregated via mean and standard deviation.
|
Up to 60 minutes after insertion
|
Implant Depth: Proximal End
Periodo de tiempo: Up to 60 minutes after insertion
|
Depth of distal end of implant beneath the skin after insertion.
Measured via high frequency ultrasound with linear probe.
Measured in centimeters below skin surface.
Measurements will be aggregated via mean and standard deviation.
|
Up to 60 minutes after insertion
|
Implant Palpability
Periodo de tiempo: Up to 15 minutes after insertion
|
A binary (yes/no) assessment of whether the implant is palpable by a physician under the skin after insertion.
Measurements will be aggregated based on percent of implants that are palpable.
|
Up to 15 minutes after insertion
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Number of Participants With Bruising
Periodo de tiempo: Up to 15 minutes after insertion.
|
Bruising may occur from inflation of the blood pressure cuff over the device being studied.
A binary assessment of bruising (yes/no) will be assessed by the physician after insertion.
|
Up to 15 minutes after insertion.
|
Presence of Bruising
Periodo de tiempo: 7 to 14 days after insertion
|
Bruising may occur from inflation of the blood pressure cuff over the device being studied.
Bruising will be assessed by the participant in a survey (binary yes/no indication of bruising around insertion site).
|
7 to 14 days after insertion
|
Number of Participants With More Bleeding Than Typical
Periodo de tiempo: Up to 10 minutes after insertion
|
Bleeding from insertion will be assessed by the physician who has extensive training with implant insertions.
The number of participants with more bleeding than is typically associated with insertion will be measured.
|
Up to 10 minutes after insertion
|
Number of Participants With Signs of Infection
Periodo de tiempo: 7 to 10 days after insertion
|
Infection will be assessed during the follow-up questionnaire. A binary assessment (yes/no) of the following will be assessed by the participant. 1) Is there currently any fluid draining from the incision? 2) Is there currently any redness or swelling of the insertion site? 3) Is there currently any bleeding from the insertion site? Participants who answer "Yes" to all three questions are deemed to have shown signs of infection. |
7 to 10 days after insertion
|
Number of Participants With Signs of Infection
Periodo de tiempo: 21 to 28 days after insertion
|
A follow-up appointment with all participants was conducted by the physician who administered the implant. A binary assessment (yes/no) of the following will be assessed for each participant by the physician. 1) Is there currently any fluid draining from the incision? 2) Is there currently any redness or swelling of the insertion site? 3) Is there currently any bleeding from the insertion site? If the physician answers "Yes" to all three questions, the participant is deemed to have shown signs of infection. |
21 to 28 days after insertion
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Kathleen H Sienko, PhD, Associate Professor
- Investigador principal: Carrie L Bell, MD, Assistant professor
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- SubQAssist0001
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Implant insertion device
-
Polares Medical SAPolares Medical, Inc.Aún no reclutando
-
Polares Medical SAPolares Medical, Inc.Aún no reclutando
-
Polares Medical SAPolares Medical, Inc.Aún no reclutandoEnfermedad degenerativa de la válvula mitral
-
Farhan KarimDePuy SynthesReclutamientoEnfermedad degenerativa del disco | Estenosis raquídea lumbar | Espondilolistesis lumbar | Estenosis foraminalEstados Unidos
-
The Royal College of Surgeons of EdinburghReclutamientoPérdida ósea alveolarEgipto, Alemania
-
Ideal Implant IncorporatedTerminadoImplantes de pechoEstados Unidos
-
Medical University of GrazReclutamientoResultado clínico de los implantes de zirconio de dos piezas en la colocación inmediata de implantesImplantación inmediata de implantes dentales de zirconio de dos piezasAustria
-
Institute FranciActivo, no reclutandoMaxilar edéntuloItalia
-
Advanced BionicsTerminadoEnfermedades Otorrinolaringológicas | Enfermedades del oído | Pérdida de la audición | Trastornos de la audiciónEstados Unidos
-
Glenn JaffeBausch & Lomb IncorporatedTerminadoOclusión de la vena central de la retinaEstados Unidos